PE Anti-MMP14 antibody [EP1264Y],Abcam,AB303602

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Human, Mouse, Rat

Application

Flow Cyt, ICC/IF, IHC-P

Conjugate

PE

Platform ID

BAB364857871

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Abcam

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Email:

[email protected]

Product Specifications
Scientific Background

Specifications

NamePE Anti-MMP14 antibody [EP1264Y]
Cat. No.AB303602
HostRabbit
IsotypeIgG
ReactivityHuman, Human, Mouse, Rat
ConjugationPE
ApplicationFlow Cyt, ICC/IF, IHC-P
ClonalityMonoclonal
Clone NumberEP1264Y
Concentration0.5 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Storage+4°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Endopeptidase that degrades various components of the extracellular matrix such as collagen (PubMed : 8015608). Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity). Activates progelatinase A/MMP2, thereby acting as a positive regulator of cell growth and migration (PubMed : 22065321, PubMed : 8015608). Involved in the formation of the fibrovascular tissues in association with pro-MMP2 (PubMed : 12714657, PubMed : 22065321). May be involved in actin cytoskeleton reorganization by cleaving PTK7 (PubMed : 20837484). Acts as a regulator of Notch signaling by mediating cleavage and inhibition of DLL1 (PubMed : 21572390). Cleaves ADGRB1 to release vasculostatin-40 which inhibits angiogenesis (PubMed : 22330140). Acts as a negative regulator of the GDF15-GFRAL aversive response by mediating cleavage and inactivation of GFRAL (PubMed : 35177851). See full target information MMP14

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.